AKT1 and type 2 diabetes mellitus: Dysregulation of PI3K/Akt signaling underlies several disorders including cancer, obesity, IR, metabolic-dysfunction-associated steatotic liver disease (MASLD) and T2D, either at the level of tissue inflammation or in the regulation of energy metabolism [33,34].